FDA Approved: SECUADO — Original Application (Noven Therapeutics, LLC)

View source ↗

Summary

FDA approved SECUADO (asenapine) from Noven Therapeutics in an original NDA (212268) for treatment of schizophrenia and acute manic/mixed episodes in bipolar I …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• SECUADO (ASENAPINE)

Snippet

ORIG AP for SECUADO (ASENAPINE)